| Income Statement | 2025-09-30 | |||
|---|---|---|---|---|
| Provision for income taxes | 0 | |||
| Net loss attributable to common stockholders | -2,739,403 | |||
| Net loss attributable to non-controlling interests | 159,360 | |||
| Net loss | -2,898,763 | |||
| Loss per share, basic | -0.58 | |||
| Loss per share, fully diluted | -0.58 | |||
| Weighted average number of common shares outstanding, basic | 4,745,089 | |||
| Weighted average number of common shares outstanding, diluted | 4,745,089 | |||
Coeptis Therapeutics Holdings, Inc. (COEPW)
Coeptis Therapeutics Holdings, Inc. (COEPW)